Search clinical trials for: standard uptake value (SUV)

Total 20662 results

Korea University

Completed

Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE

sRAGE Level | SUV and TBR Levels in FDG PET
Susannah Ellsworth

Completed

Stereotactic Body Radiation Therapy (SBRT) for Liver Mets

Liver Metastases

United States
Assiut University

Not yet recruiting

Validity of Mediastinal Blood Pool SUV Ratio

Validity of Blood Pool SUV Ratio in Identification of Malignancy in Case of Diseased Liver
Daping Hospital and the Research Institute of Surgery...

Recruiting

Application of FDG Combined With FAPI PET Dual Imaging in the Diagnosis and Staging of Oropharyngeal and Laryngeal Cancer

Cancer

China
Diwakar Davar
CellSight Technologies, Inc.; Checkmate Pharmaceuticals

Active, not recruiting

Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab

Melanoma

United States
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Wake Forest University Health Sciences
Lucerno Dynamics, LLC

Terminated

Infiltration Effect on SUV

Dose Response Relationship, Drug

United States
Central Hospital, Nancy, France

Completed

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction (177Lumen)

Refractory Meningioma

France
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification

Positron Emission Tomography-Magnetic Resonance (PET-MR)

United States
Cairo University
Mohamed El Sharkawy; Yomna Bayoumi; mohamed hisham gouda; Dina latif

Completed

Castror Oil for Labor Induction in Women With Previous Cesarean Section

Induction of Labor

Egypt
West China Hospital
Zhejiang Cancer Hospital; Hebei General Hospital; Beijing Tongren Hospital; The... and other collaborators

Unknown

Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans

Hyperthyroidism | Tomography | Emission-Computed | Single-Photon

China
Academisch Ziekenhuis Maastricht

Recruiting

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Lymphoma | Lung Cancer

Netherlands
Rambam Health Care Campus

Completed

SUV Max as Predictor of Outcome in Cervical Cancer

Cervical Cancer

Israel
Centre Henri Becquerel

Completed

Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival (RTEP2)

NSCLC | Lung Cancer

France
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

SUV on PSMA PET/CT in Non-Prostate Tumors

Cancer

Canada
M.D. Anderson Cancer Center

Completed

Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the Breast

Breast Cancer

United States
Centre Henri Becquerel

Unknown

Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma (RTEP3)

Oesophageal Cancer

France
University of Arizona
National Cancer Institute (NCI)

Recruiting

SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants

Other Skin Changes Due to Chronic Exposure to Nonionizing Radiation

United States
Sujata Vaidya
Smt. Kashibai Navale Medical College and General Hospital; Health Solutions...

Completed

Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT. (SHARP)

Coronary Artery Disease | Ischemic Heart Disease | Deep Vein Thrombosis | Peripheral Arterial Diseases | Vascular Disease | Cerebro Vascular Disease

India
Maastricht Radiation Oncology
Maastricht University Medical Center

Completed

Prediction of Clinical Response and Outcome in Uterine Cervix Cancer

Cervix Cancer

Netherlands
University Hospital, Basel, Switzerland
Siemens Corporation, Corporate Technology

Recruiting

xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease (xSPECT MPI)

Coronary Artery Disease

Switzerland
Kurume University
Eisai Inc.; Mebix Inc

Completed

An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Insomnia

Japan
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
University of Oxford

Completed

A Study of a New Vaccine Against Two Types of Ebola

Ebola

United Kingdom
Jewish General Hospital

Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Neuroendocrine Tumors

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
European Lung Cancer Working Party

Active, not recruiting

Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.

Non Small Cell Lung Carcinoma

Belgium
Chestnut Hill Health System

Completed

Lipid Lowering in Patients With Statin Intolerance

Coronary Artery Disease | Hyperlipidemia

United States
GCS Ramsay Santé pour l'Enseignement et la Recherche

Recruiting

Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy (QUANTI-SUV)

Cardiac Amyloidosis

France
Centre Henri Becquerel

Completed

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT (RTEP4)

Carcinoma, Non-Small-Cell Lung | Bronchial Neoplasms

France
Centre Henri Becquerel

Completed

Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer (VOSETEP)

Infiltrating Ductal Carcinoma

France
Universitaire Ziekenhuizen KU Leuven
Flemish League Against Cancer

Terminated

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer

Belgium
Cumhuriyet University

Completed

Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?

Lung Neoplasms | Gene, p53

Turkey
King's College London
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Optimising Molecular Radionuclide Therapy (SELFIE)

Hyperthyroidism | Neuroendocrine Tumors | Thyroid Carcinoma | Thyroid Cancer

United Kingdom
University of Roma La Sapienza

Completed

Androgen for Leydig Cell Proliferation (ALCeP)

Klinefelter Syndrome | Hypergonadotropic Hypogonadism | Hypergonadotropic Azospermia | Hypergonadotropic Cryptozoospermia

Italy
Central Hospital, Nancy, France

Completed

Absolute Quantification in Bone Scintigraphy (QUANTOSS-3D)

Scintigraphy Quantification

France
University Hospital, Toulouse

Completed

Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma (PET-FETII)

Low Grade Glioma

France
GE Healthcare
i3 Statprobe

Terminated

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Normal Pressure Hydrocephalus

United States
GE Healthcare
Covance; i3 Statprobe

Completed

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Brain Fibrillarab Levels

United States
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Healthy

United States
GE Healthcare
i3 Statprobe

Completed

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Normal Pressure Hydrocephalus

United States
National University Hospital, Singapore

Not yet recruiting

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers (VALUE-CHECK)

Carcinoma, Hepatocellular | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal Cancer | GastroEsophageal Cancer

Singapore
RenJi Hospital

Recruiting

the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

Immunotherapy | Locally Advanced Cervical Carcinoma | Concurrent Chemoradiotherapy

China
Qinghai Red Cross Hospital

Recruiting

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Advanced Cancer | Progression Free Survival | Olanzapine

China
Clinical Hospital Center Rijeka

Not yet recruiting

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS (CEMinDCIS)

DCIS | Breast Carcinoma in Situ | Calcification

Croatia
Centre Hospitalier Emile Roux

Recruiting

Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists (DOLOREPIT)

Chronic Pain

France
Ottawa Hospital Research Institute

Recruiting

Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age

Pneumococcal Vaccines | Immunization Coverage

Canada
Novartis Pharmaceuticals

Recruiting

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma (LEDA)

Follicular Lymphoma (FL)

Australia, Korea, Republic of, Spain, Singapore, Poland, Taiwan, Hungary, Czechia, Romania, Slovakia
Tianjin Medical University Cancer Institute and...

Not yet recruiting

A Multicenter, Phase 2 Study Evaluating the Value of Radiotherapy in Advanced Diffuse Large B-cell Lymphoma Patients With Extranodal Involvement and Large Tumors Undergoing Immunochemotherapy for PET-CT Assessment of Complete Remission

Radiotherapy | Advanced Diffuse Large B-Cell Lymphoma | Extra-nodal Involvement, Large Mass

Search clinical trials for: standard uptake value (SUV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations